Congratulations to UroPrecision: Embark on a remarkable journey

I would like to express my sincere congratulations to you on the first issue of the new journal—UroPrecision. As a urologist who dedicated most of my life to clinical and basic urology for decades of years, I am immensely proud to witness the launch of a journal that is dedicated to speeding up the growth and integration of precision medicine principles in the field of urology as well as building up the influence of important research results in the international community. First of all, I must commend the distinguished editorial board of UroPrecision, which comprises internationally recognized experts. The wealth of knowledge, expertise, and experience brought by these esteemed professionals ensures that the journal maintains the highest standards of scientific rigor and relevance. It is truly a privilege to have such eminent scholars guiding the direction and content of UroPrecision, guaranteeing its impact and influence in the field of urology. Furthermore, the field of precision medicine has emerged as a transformative approach in urology, offering tailored therapies based on individual characteristics and genetic profiles. In the field of urology, the application of robotics, minimally invasive techniques, and precision oncology have revolutionized the field, enabling precise interventions and better patient outcomes. As an academic journal in urology, UroPrecision holds a pivotal role in shaping the future of our field. By providing an esteemed platform for researchers and clinicians to publish their work, exchange insights, and disseminate knowledge, the journal fosters collaboration and empowers the global urologic community. UroPrecision's multidisciplinary approach bridges the gap between research and clinical practice, inspiring innovative approaches to urologic care and facilitating the translation of scientific discoveries into tangible improvements in patient outcomes. The collaboration fostered between clinicians and researchers, facilitated by platforms like UroPrecision, will undoubtedly expedite the progress of precision medicine in urology and pave the way for further advancements in personalized patient care. In addition to serving as a repository of high-quality research, UroPrecision contributes to the continuous professional development of urologists and researchers worldwide. By featuring state-of-the-art reviews, impactful case reports, thought-provoking editorials, evidence-based clinical guidelines, and so on, the journal serves as an invaluable resource, keeping practitioners at the forefront of the latest advancements, emerging trends, and best practices in the field. I extend my deepest appreciation to the editorial team for their unwavering commitment to promoting excellence in urological research and clinical practice. I am confident that this journal will catalyze advancements in precision urology globally. Once again, please accept my warmest congratulations on the successful launch of UroPrecision. I am excited to witness that this journal will become a part of the remarkable journey toward precision medicine in urology. Not applicable. The author declares that there is no conflict of interest except for Yinglu Guo, who is the Honorary Editors-in-Chief of UroPrecision. He was excluded from the peer-review process and all editorial decisions related to the acceptance and publication of this article. Peer review was handled independently by the other editors to minimize bias. Not applicable.